Lannett Company Inc (NYSE:LCI)
| 7.94 Delayed Data As of 4:00pm ET |  +0.53 / +7.23%Today’s Change | 5.16 Today|||52-Week Range 15.52 | -10.03% Year-to-Date |
Latest LCI News | Press Releases
| Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks Jun 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.40 |
| Today’s open | 7.60 |
| Day’s range | 7.50 - 8.07 |
| Volume | 696,101 |
| Average volume (3 months) | 683,009 |
| Market cap | $308.7M |
Data as of 4:00pm ET, 06/05/2020
Growth & Valuation
| Earnings growth (last year) | -1,035.38% |
| Earnings growth (this year) | -55.91% |
| Earnings growth (next 5 years) | +7.85% |
| Revenue growth (last year) | -4.26% |
| P/E ratio | NM |
| Price/Sales | 0.35 |
| Price/Book | 0.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TCRRTCR2 Therapeutics In... | +0.39 | +3.14% |
| OVIDOvid Therapeutics In... | -0.07 | -1.29% |
| VRCAVerrica Pharmaceutic... | +1.09 | +9.47% |
| MNLOMenlo Therapeutics I... | -0.16 | -7.27% |
Data as of 5:52pm ET, 06/05/2020
Financials
| Next reporting date | September 1, 2020 |
| EPS forecast (this quarter) | $0.27 |
| Annual revenue (last year) | $655.4M |
| Annual profit (last year) | -$272.1M |
| Net profit margin | -41.52% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Philadelphia, Pennsylvania |
Forecasts
